Company intelligence / Profile preview

Siegfried

Zofingen, Aargau, Switzerlandsiegfried.ch ↗

Ownership: Public · SFZN
Employees: ~3886
Development stage: Commercial

Overview

Siegfried is one of the world’s leading contract development and manufacturing organizations. It provides integrated services for the development and production of active pharmaceutical ingredients (APIs), intermediates, controlled substances, and finished dosage forms. The company operates 13 sites across three continents with over 150 years of experience in pharmaceutical chemistry. It serves more than 500 customers globally—including major pharma companies—and has played key roles in large-scale projects such as COVID-19 vaccine production.

Modalities: Small moleculeBiologicPeptide
Industry: Contract Manufacturing Organization

Partnerships

Manufactures for >500 global pharma customers; specific partnerships not disclosed

Financials

Market cap: $122.7M
Total revenue: $77K

Beyond the preview

Go deeper on Siegfried.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Siegfried.

Explore the full profile